China SXT Pharmaceuticals (SXTC) Shares Outstanding (2018 - 2026)

China SXT Pharmaceuticals (SXTC) has reported Shares Outstanding (Entity) for 5 consecutive years, with $35.0 the latest figure, recorded in Q1 2022.

• Quarterly Shares Outstanding (Entity) rose 34.62% year-over-year to $35.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $35.0 (up 34.62% YoY) and the FY2022 annual result came in at $35.0, up 34.62% from the prior year.
• Shares Outstanding (Entity) advanced to $35.0 in Q1 2022 per SXTC's latest filing, from $26.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for SXTC reached as high as $35.0 in Q1 2022 and fell as low as $8.0 in Q1 2018.
• A 5-year average of $17.43 and a median of $10.0 in 2020 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2020 — Shares Outstanding (Entity) increased 11.11% — and 2021, when it surged 160.0%.
• Year by year, Shares Outstanding (Entity) stood at $8.0 in 2018, then advanced by 12.5% to $9.0 in 2019, then surged by 188.89% to $26.0 in 2020, then changed by 0.0% to $26.0 in 2021, then jumped by 34.62% to $35.0 in 2022.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $35.0, $26.0, and $26.0 for Q1 2022, Q1 2021, and Q3 2020 respectively.